Insiders Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			Pre-market 08:54:52 am
125.7 ^USD	+7.13%		125.5	-0.14%

11:26am	ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...
11:26am	Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	May. 10	MT
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
China's drugmakers can't sell mRNA shots but haven't quit yet	Apr. 19	RE
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	Apr. 16	MT
Moderna CEO: 'Excited' About Future Following 4Q Revenue	Feb. 22	MT
Moderna Insider Sold Shares Worth $936,981, According to a Recent SEC Filing	Feb. 16	MT
Moderna Insider Sold Shares Worth $2,342,098, According to a Recent SEC Filing	Feb. 16	MT
Lonza chairman to step down, drugmaker confirms targets, shares soar	Jan. 26	RE
Moderna Insider Sold Shares Worth $1,558,500, According to a Recent SEC Filing	Jan. 17	MT
Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector	Jan. 16	MT
Top Stories at Midday: Boeing Declines After FAA Grounding; Twilio Names New CEO; Johnson & Johnson May Pay $700 Million Talc Probe Settlement; Moderna Rises on $6.7 Billion COVID-19 Vaccine Sales	Jan. 08	MT
Moderna Insider Sold Shares Worth $4,500,450, According to a Recent SEC Filing	Dec. 28	MT
Stéphane Bancel, CEO of Moderna: Merck-Moderna vaccine reduces risk of skin cancer recurrence	Dec. 14	MT
Moderna CEO Stephane Bancel to Assume Responsibility for Sales, Marketing in 2024 Amid Preparations for Product Launches	Dec. 12	MT
Moderna: departure of sales director in sight	Dec. 12	CF
Moderna chief commercial officer steps down	Dec. 12	RE
Moderna Announces Changes to Commercial Organization	Dec. 12	CI
Moderna Chairman Afeyan on Industry Outlook, Strategy, AI	Nov. 09	MT
Arbutus Biopharma Posts Q3 Net Loss, Lower Revenue; CEO to Retire, 24% Research Staff Cut	Nov. 07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST